JACKSONVILLE, Fla. — With support from the state of Florida, Mayo Clinic’s Florida campus has opened a state-of-the-art laboratory for nanotechnology research, an emerging field of science that studies and applies materials that are the size of an atom.
The laboratory is a key part of Mayo Clinic’s new Translational Nanomedicine Program. The goal is to develop, test and apply tiny materials in diagnosing and treating patients, particularly those with cancer.
“Mayo Clinic is committed to investing in research to provide the latest in care for our patients,” says Gianrico Farrugia, M.D., CEO, Mayo Clinic in Florida. “This laboratory for nanotechnology research will ensure we continue to provide cutting-edge cancer therapy for Jacksonville, the state of Florida and the entire Southeastern U.S.”
Many materials change their properties at the atomic level, making nanoparticles potentially useful in delivering therapeutic drugs to cells and helping diagnose, treat, and monitor disease from within. One nanometer equals one billionth of a meter.
Potential uses for nanomedicine include:
Nanotechnology not only has potential applications for cancer, but also for cardiovascular disease, diabetes, and other immune disorders, including rheumatoid arthritis, asthma and allergic conditions.
The lab will be directed by Debabrata (Dev) Mukhopadhyay, Ph.D., a world-renowned scientist in cancer and nanotechnology. He was recruited to Mayo Clinic to open the lab with a $2 million grant from the state of Florida.
MEDIA CONTACT: Kevin Punsky, Mayo Clinic Public Affairs, 904-953-0746, email: email@example.com
Journalists: Sound bites with Dr. Mukhopadhyay are available in the downloads.
Dr. Mukhopadhyay has a broad background in tumor microenvironment, nanomedicine and vascular biology. He has training and expertise in cancer, cardiovascular diseases, diabetes, and angiogenesis (the development of new blood vessels). He and his team of researchers help support ongoing National Institutes of Health (NIH) grants, and collaborate with others at national and international institutions. His laboratory will work to develop collaborations with Florida-based institutions, as well.
“We will be building a strong collaborative platform in translational nanomedicine, with multidisciplinary approaches to innovative patient care,” Mukhopadhyay says.
Nanotechnology is aimed at bringing new solutions to patients of Mayo Clinic’s Comprehensive Cancer Center, one of just two NIH-designated centers in Florida. The national center includes three locations – Mayo’s campuses in Jacksonville; Rochester, Minnesota; and Phoenix/Scottsdale, Arizona.
Mayo Clinic has invested more than $1.5 million in equipment for nanotechnology on the Florida campus, including:
“Nanotechnology in medicine is going to have a major impact on patient care, with more effective and targeted therapy,” says Dr. Mukhopadhyay.
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or https://newsnetwork.mayoclinic.org/